Elicera Therapeutics AB
ELIC | FN
Overview
Corporate Details
- ISIN(s):
- SE0015382080 (+1 more)
- LEI:
- 549300I35L0R4INBFG27
- Country:
- Sweden
- Address:
- C/O Elicera Therapeutics AB, 402 24 Göteborg
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Elicera Therapeutics AB develops immuno-oncology therapies based on CAR T-cell technology. They target various cancer indications.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Margareth Jorvid | Other | Other | 21,700 | 40,145.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
CHOSA Oncology AB | Sweden | CHOSA | |
|
Cinclus Pharma Holding AB | Sweden | CINPHA | |
|
Circio Holding ASA | Norway | CRNA | |
|
CIZZLE BIOTECHNOLOGY HOLDINGS PLC | United Kingdom | CIZ | |
|
CLAL Biotechnology Industries Ltd. | Israel | CBI | |
|
Combigene AB | Sweden | COMBI | |
|
Compugen Ltd. | Israel | CGEN | |
|
Corline Biomedical AB | Sweden | CLBIO | |
|
Curasight A/S | Denmark | CURAS | |
|
Curevac | Germany | CVAC |